Abstract. Forkhead box transcription factor, class O (FOXO) is a mammalian homologue of DAF-16, which is known to regulate the lifespan of Caenorhabditis elegans and includes subfamilies of forkhead transcription factors such as AFX, FKHRL1, and FKHR. FKHR is phosphorylated on three sites (Thr-24, Ser-256, and Ser-319) in a phosphatidylinositol 3-kinase (PI3K)/ Akt-dependent manner, thereby inhibiting death signals. We here documented dephosphorylation of FKHR following transient forebrain ischemia with its concomitant translocation into the nucleus in neurons in gerbil and mouse brains. The activation of FKHR preceded delayed neuronal death in the vulnerable hippocampal regions following ischemic brain injury. The FKHR activation was accompanied by an increase in DNA binding activity for FKHR-responsive element on the Fas ligand promoter. We also defined FKHR-induced downstream targets such as Fas ligand and Bim in brain ischemia. Therefore, we propose a new strategy to rescue neurons from delayed neuronal death by promoting the survival signaling. Sodium orthovanadate, a protein tyrosine phosphatase inhibitor, up-regulated Akt activity in the brain and in turn rescue neurons from delayed neuronal death by inhibiting FKHR-dependent or -independent death signals in neurons.
Introduction
The forkhead box transcription factor, class O (FOXO) is mammalian homologue of DAF-16, which is known to regulate life span of Caenorhabditis elegans (1) and includes subfamilies of forkhead transcription regulators such as FKHR (FOXO1), FKHRL1 (FOXO3a), and AFX (FOXO4). The FOXO factors share DNA-binding specificity to a core consensus site called the Forkhead-responsive element (2) (Fig. 1B) and downstream targets of phosphatidylinositol 3-kinase (PI3-K)/ protein kinase B (Akt) signaling. The FOXO factors are phosphorylated in vivo on multiple threonine and serine residues (T1, T2, S1, S2, and S3) as shown in Fig. 1A . Three of these phosphorylation sites (T1, S1, and S2) have a consensus sequence for phosphorylation by Akt. Serum-and glucocorticoid-inducible kinase (SGK) underlying PI3-K pathways also phosphorylates T1 and S2 of FKHRL1 (3) . FOXOs are phosphorylated by Akt on these sites in vivo following stimulation with survival factors. Reporter assays for transcriptional activity and mutational analysis of the phosphorylation sites T1, S1, and S2 show that Akt-induced phosphorylation inhibits transcriptional activity of the FOXO members. The phosphorylation-dependent translocation of the FOXO members between the nucleus and the cytoplasm has been extensively studied. Homologous sequences for nuclear localization signal (NLS) and nuclear export signal (NES) have been identified within the FOXO members as shown in Fig. 1A . Shuttling of FOXOs between nucleus and cytoplasm is regulated by accessory proteins such as importins or exportins (Crm1). The association between FOXO and importins and exportins is also regulated by the small GTPase Ran. FKHR, a FOXO family member, is phosphorylated on three sites (Thr-24, Ser-256, and Ser-319) in a PI3-Kdependent manner (4) , and phosphorylation on all or a subset of these sites contributes to the inactivation of its transcriptional activity (5) . The phosphorylation of murine FKHR at Ser-253 (corresponding to Ser-256 in human FKHR) is required for phosphorylation of the other two sites for Akt (5) . In the case of FOXO, one of the NLS lies near the Akt-dependent phosphorylation site S1. Upon phosphorylation on S1 by Akt, the NLS in FOXO is inactivated. The 14-3-3 protein possibly recognizes the S1 phosphorylated form of FOXO and exports it to the cytoplasm by masking the NLS and / or by promoting nuclear export. However the importin that binds to the NLS remains unidentified. The function of additional Akt-dependent phosphorylation sites of T1 and S2 also remains unclear. Nuclear export of FOXOs is inhibited by leptomycin B treatment, implying involvement of Crm1 in the nuclear export. Recently, Zhao et al. (6) proposed two putative NES in the C terminal region and one NES near S3. Although exportin (Crm1) may not directly bind to the NES, the phosphorylation of T1 and S3 possibly affects the Crm1 binding to the NES. The phosphorylation of T1 and S2 does not affect the binding between FOXO and Crm1. In addition, Akt-independent phosphorylation sites were also defined. These sites include Ser268 (S3) and Ser329 (S3) in AFX and FKHR, respectively, and Thr447 / 452 (T2) in AFX. Dual-specific tyrosine-phosphorylated and -regulated kinase 1a is responsible for the S3 phosphorylation (7) . An undefined downstream kinase of Ras-Ral signaling accounts for the T2 phosphorylation (8) . Although the S3 phosphorylation in FKHR affects nuclear localization, the physiological relevance of these phosphorylations in the shuttling between the nucleus and cytoplasm remains unknown. Rena et al. (9) recently found that Ser319 phosphorylation in FKRH is required for subsequent phosphorylation of Ser322 and Ser325 by casein kinase 1 (CK1). Together with Ser319 and Ser329, the CK1-induced phosphorylation promotes the association of FKHR and Ran. Thus, a precise mechanism for the nuclear export of FOXOs can be proposed as shown in Fig. 2 . Following FKHR phosphorylation of T1, S1, and S2 by Akt in the nucleus, its association with 14-3-3 protein, Ran, and Crm1 contributes to the export of FKHR from the nucleus.
Generally, once survival factors are depleted, FOXOs are dephosphorylated and translocate into the nucleus (5, 10 -13). Furthermore, activation of FOXOs induces apoptosis (5, 14 -16) . FOXO-induced cell death is possibly caused by expression of Fas ligand and Bcl-2-interacting mediator of cell death (Bim), a Bcl-2 family member (10, 17) . It has not been documented whether the activation of FOXOs is involved in the mechanisms of ischemic cell death. Therefore, we documented the activation mechanism of FOXO family members following brain ischemia and their downstream targets underlying neuronal death. Phosphorylation of T1, S1, and S2 by Akt activity through PI3-K underlying growth factor signaling is a crucial step of the FOXO function. Serum-and glucocorticoid-inducible kinase (SGK) underlying the PI3-K pathway also phosphorylates T1 and S2. The S2 phosphorylation by Akt is required for subsequent phosphorylation of Ser 322 and Ser325 in FKHR by casein kinase 1 (CK1). Together with these phosphorylations, the S3 phosphorylation by the dual-specific tyrosine-regulated kinase 1a (DYRK1a) may contribute to the nuclear export of FOXO. In addition, T2 in the C terminal regions is also phosphorylated by an undefined kinase underlying the Ras-Ral pathways as described in the text.
Decreased Akt activity following brain ischemia
Transient forebrain ischemia results in delayed neuronal death of pyramidal neurons in the hippocampal CA1 region. Although molecular mechanisms underlying the pathogenesis of delayed neuronal death is unclear at present, histological, and biochemical evidences demonstrated involvement of apoptosis in dying cells after ischemia. Activation of Akt has been demonstrated to protect cells from apoptosis (18, 19) . We recently reported that a decreased Akt activity is involved in ischemic-induced cell death (20 -23) and that an increased Akt activity account for neuroprotection in ischemic tolerance in gerbil hippocampal neurons (24) . Akt is phosphorylated on two residues, Thr-308 and Ser-473, prior to it activation, and treatment with wortmannin, an inhibitor for PI3-K, prevents the Akt activation (25) . Plasma membrane translocation is also an essential step in the Akt activation. Thereafter, the activated Akt detaches from the plasma membrane and translocates to the nucleus. Several potential substrates for Akt related to cell survival include Bad, caspase 9 in the cytoplasm, and cAMP-responsive element binding protein (CREB), NF-κB, and FOXOs in the nucleus (10, 16, 26 -32) .
Dephosphorylation and activation of FKHR following brain ischemia
Because Akt phosphorylates FOXOs such as FKHR and FKHRL1 as downstream targets in cell survival signaling (3, 10, 16, 30) , we examined changes in FKHR phosphorylation as well as Akt phosphorylation after transient forebrain ischemia as shown in Fig. 3 . The transient decrease in the Akt phosphorylation was associated with decreased Akt activity in the gerbil hippocampus (20) . Immunoblotting analysis with antiphospho-FKHR-Ser-256 antibody revealed that ischemia induced dephosphorylation of FKHR-Ser-256 in the CA1 region immediately (0 h) and 0.5 and 1 h after reperfusion without changes in the FKHR protein levels (Fig. 3B) . The FKHR-Ser-256 phosphorylation returned to the basal level within 2 h after reperfusion. The FKHR-Ser-256 dephosphorylation was closely correlated with the dephosphorylation of Akt-Ser-473. This implicates that decreased Akt activity accounts for the decreased FKHR phosphorylation. Because dephosphorylation of FKHR is associated with translocation into the nucleus as described above, we investigated changes in localization of FKHR in the CA1 regions after subcellular fractionation. In sham-operated animals, FKHR mainly localized in the cytosolic fractions 
Crm1 together with 14-3-3 protein and Ran are involved in the nuclear export through nuclear export signal for the FKHR molecule. (Fig. 3C) . As expected, FKHR significantly translocated to the nuclear fractions immediately after reperfusion (Fig. 3C) . To confirm dephosphorylation and translocation of FKHR following ischemia in the hippocampal CA1 regions, slices from sham-operated and ischemic animals were double-stained with conventional FKHR antibody and phospho-specific antibody for FKHR-Ser-256, as shown in Fig. 4 . In shamoperated animals, immunoreactivity for the phosphospecific antibody showed that phosphorylated FKHR predominantly localized in the cytoplasm of the pyramidal neurons in the CA1 regions (Fig. 4A) . Following transient ischemia, the immunoreactivity markedly decreased in the cytoplasm (Fig. 4B) . In contrast, immunoreactivity against conventional FKHR antibody was relatively weak in the CA1 pyramidal neurons in the sham-operated animals (Fig. 4C) . However, the transient ischemia caused apparent accumulation of FKHR into the nuclei of the CA1 pyramidal neurons (Fig. 4D) . Taken together, dephosphorylation of FKHR contributes to its nuclear transport in the vulnerable CA1 neurons as previously speculated.
Forkhead consensus binding sites were characterized as shown in Fig. 1B (33, 34) . Consensus element for FOXO binding, termed the Forkhead-responsive element was also reported within the promoter of the Fas ligand gene (10) . To determine whether FKHR localized into the nuclei has a DNA binding ability, we performed gel mobility shift analysis using the Forkhead-responsive element oligonucleotide probe derived from the promoter of Fas ligand gene. The ischemia induced an increase in the binding activity to Forkhead-responsive element in nuclear extracts from the CA1 regions (21) . Orthovanadate, an activator of Akt, treatments reduced the increased binding activity to the basal levels observed in sham-operated animals. Supershift analysis showed that the DNA binding complexes were shifted by antibodies against FKHR, FKHRL1, and AFX (21). 
Downstream targets for FKHR in delayed neuronal death
Fas (also called CD95, APO-1), a member of the TNF receptor family, and Fas ligand (also called CD95-L, APO-1L) play important roles in apoptosis (35) . Activation of Fas leads to formation of a death-inducing signaling complex composed of the Fas-associated death domain and pro-caspase 8. Pro-caspase 8 is proteolytically cleaved and consequently activates caspase pathways and thereby cells are led to apoptosis. The Fas / Fas ligand system, which was first documented in the immune system, is also important for pathophysiology of the central nervous system such as Alzheimer's disease, multiple sclerosis, trauma, and ischemia. Recently the Fas/ Fas ligand system was shown to be involved in the mitochondrial apoptotic pathway by cleaving the Bcl-2 family member, Bid (36, 37) . FOXOs are known to induce the expression of cell death-related genes such as Fas ligand and Bim, a proapoptotic Bcl-2 family member (10, 17) . Immunoblotting analysis demonstrated expression of Fas ligand in the CA1 regions stimulated 2 days after ischemia / reperfusion (21) . Orthovanadate treatments prevented the ischemiainduced expression of Fas ligand. The immunoreactivities for Fas ligand increased in the CA1 pyramidal neurons 2 days after reperfusion. Current studies demonstrated involvement of the Fas / Fas ligand signaling in the pathophysiology of the central nervous system. For example, Fas ligand mRNA expression increased in the cerebral cortex following permanent middle cerebral artery occlusion (MCAO) in adult rats (38) and Fas ligand mRNA and its protein were expressed in the cerebral cortex after reversible MCAO in adult rats (39 -41) . Furthermore, lpr mice expressing mutant Fas without its function had significantly smaller infarct size after MCAO as compared to the wild type mice (41) . We also confirmed that the activation of FKHR was associated with an increased expression of Fas ligand (21) . Because the dephosphorylation of FKHR was transient and occurred immediately after reperfusion, further experiments are needed to confirm the relevance of induction of Fas ligand and activation of caspase-8 in the delayed neuronal death following ischemia. Because activation of Fas is accompanied with recruitment of procaspase-8 into the death-inducing signaling complex, thereby activating caspase-8 (42), we should identify the complex in the apoptotic neurons.
Activation of FOXOs also accounted for expression of another apoptotic protein, Bim, a BH3-only member of the Bcl-2 family (17) . Developing sympathetic neurons die by apoptosis when deprived of nerve growth factor (NGF). Bim is induced after NGF deprivation, in which FKHRL1 is involved in the Bim expression (43) . FOXO binding sites are required for activation of the bim promoter by FKHRL1 and NGF withdrawal. Induction of Bim is also associated with vulnerability of hippocampal neurons after experimental seizures and in hippocampi from patients with intractable temporal lobe epilepsy (44) . To address the relevance of activation FKHR in the Bim induction in ischemic brain injury, expression of Bim was also investigated in the mouse bilateral common carotid artery occlusion model. As shown in Fig. 5 , Bim protein level markedly increased 12 h after ischemia / reperfusion. The Bim expression was associated with FKHR activation in the same animals. In addition to phosphorylation of FOXOs, deacetylation of FOXOs by SIRT1 is known to regulate their transcriptional activities (45) . Since hydrogen peroxide induces the acetylation of FOXO4 and inhibits its transcription activity, the acetylation of FOXO family members should be investigated following brain ischemia.
Akt/ FOXO pathways are potential targets for neuroprotective drugs
In conclusion, activation of survival signals through Akt / FOXO pathways is a potential strategy for clinical treatments not only for ischemic insult but also for neurodegenerative disorders. In addition to NGF, other neurotrophic factors including IGF-1, basic FGF, and brain-derived neurotrophic factor (BDNF) are potentially important therapeutic agents for neurodegenera- tive disorders such as Alzheimer's and Parkinson's diseases. The benefits of these neurotrophic treatments include activation of PI3-K / Akt pathways concomitant with MAPK activation, which is also crucial for upregulation of survival signaling. However, like most proteins, neurotrophins have poor medical properties, including limited penetration into brain tissue and poor chemical stability in blood circulation. Our goal is to develop stable, small molecules having neurotrophin mimetic functions to prevent neuronal loss and to maintain neuronal connection. We have introduced a novel approach for creating Akt stimulants as a small compound. Orthovanadate elicited powerful neuroprotective effects on the ischemic insults not only in the brain (20 -23) but also in the heart (46) . Since orthovanadate treatment upregulated the MAPK pathway as well as PI3-K / Akt signaling, vanadium compounds are attractive candidates for neuroprotective drugs. Furthermore, FOXO-related transcription factors were defined as deteriorative transcriptional factors in brain ischemia. Although further extensive study is required to determine the functional relevance of FOXO family members including AFX, FKHR, and FKHRL1 and their phosphorylation in the neurodegeneration, the transcription factors are also attractive targets for novel drug development in the therapy for neurodegenerative disorders.
